← All companies

EMR · CIK 32604

What Emerson Electric Co. told the SEC could break it.

Emerson's disclosures center on the exposures of a globally distributed manufacturer. Of roughly 120 manufacturing locations at the end of fiscal 2025, about 85 are outside the U.S., primarily in Europe and Asia, and it sells, makes and buys worldwide — so it is subject to changes in trade terms, tariffs, taxation, exchange controls and earnings-repatriation rules across many jurisdictions, plus currency swings. Its growth strategy of acquisitions and divestitures (such as buying the rest of AspenTech and the $8.2 billion National Instruments deal) hinges on regulatory approvals at home and abroad — AspenTech's planned Micromine purchase was terminated as Russian approval grew unclear. It also flags rising reliance on AI as a source of reputational, competitive and legal risk.

4 self-disclosed vulnerabilities, pulled from its own filings — each in the company’s words, with the source. This is the risk register almost nobody reads.

In its own words

What could break it.

Regulatory & policy

  • foreign-trade/government-policy changes (trade terms, tariffs) on globally sourced/sold productsmedium

    Emerson's substantial U.S. and international operations expose it to changes in laws or policies (and their interpretations) governing the terms of foreign trade, taxation, investment and exchange controls across numerous jurisdictions, which could adversely affect results.

    Our U.S. and international operations subject the Company to changes in government regulations and policies in a large number of jurisdictions around the world, including those related to trade, investments, taxation, exchange controls and repatriation of earnings.

  • M&A/divestiture regulatory-approval dependence (AspenTech buyout, NI; AspenTech-Micromine terminated over Russian approval)low

    Emerson pursues growth via strategic acquisitions/divestitures (e.g., buying the remaining AspenTech shares, the $8.2B National Instruments acquisition) that require favorable conditions and regulatory approvals in domestic and foreign jurisdictions; AspenTech's agreement to acquire Micromine was terminated after Russian regulatory approval became increasingly unclear.

    These activities require favorable environments to execute these transactions, and we may encounter difficulties in obtaining the necessary regulatory approvals in both domestic and foreign jurisdictions.

    SEC filing →As of 2025

Geographic concentration

  • global manufacturing/sales — ~85 of 120 plants non-U.S. (Europe/Asia); trade/tariff/exchange-control/repatriation regulation + FXmedium

    Emerson had ~120 manufacturing locations at FY2025 (≈35 U.S., ≈85 outside the U.S., primarily Europe and Asia), sells/manufactures/purchases globally with significant non-U.S. sales, and is subject to changes in government regulations/policies on trade, investments, taxation, exchange controls and repatriation across many jurisdictions, plus currency fluctuations.

    the Company had approximately 120 manufacturing locations worldwide, of which approximately 35 were located in the United States and 85 were located outside the United States, primarily in Europe and Asia, and to a lesser extent in Canada and Latin America.

    SEC filing →As of 2025

Other disclosures

  • increasing reliance on AI in operations/products — reputational, competitive and legal-liability risklow

    Emerson's businesses increasingly rely on artificial-intelligence solutions to optimize operations, improve customer experiences and enhance products/services; while it presents opportunities, AI introduces risks that could result in reputational harm, competitive harm and legal liability, adversely affecting results.

    Our businesses increasingly rely on artificial intelligence solutions to optimize our operations, improve customer experiences, and enhance our products and services. While the use of artificial intelligence presents significant opportunities, it also introduces a range of risks that could result in reputational harm, compet[itive harm, and legal liability]

    SEC filing →As of 2025

In the MyPRIA app, this is checked against the companies you actually own.

← World Watch